SuperSonic Imagine will present its new Aixplorer MACH 30 ultrasound and its new breast imaging solutions at the SIFEM confe...
12 Juin 2019 - 6:10PM
SuperSonic Imagine (Euronext: SSI, FR0010526814, PEA-PME eligible),
a company that specialises in ultrasound medical imaging
(echography), will present the breast imaging solutions available
on its new Aixplorer MACH 30 ultrasound machine during the annual
conference of the French Society for Women’s Imaging (SIFEM) held
from 13th to 15th June 2019 in Lille. This year, the theme of the
conference is: ‘Imaging useful for clinicians: present and future’.
Since its creation, SuperSonic Imagine has
enjoyed an excellent reputation for diagnosing breast lesions,
especially in dense breast tissues. Furthermore, the benefits of
ShearWave elastography (SWE) are discussed in over 135
peer-reviewed publications with two major multi-centre studies, one
in the United States & Europe1 (1,600 patients) and one in
China2 (1,021 patients). ‘The SIFEM conference is an opportunity
for SuperSonic Imagine to present its ultrasound solution focused
on breast imaging using the Aixplorer MACH 30. It provides
unparalleled performance and innovations like SWE PLUS and improved
image quality in B-mode with SonicPure, a smart ultrasound signal
processing system’, explains Yves Tenaglia, the SuperSonic
Imagine director and vice-president for Europe, the Middle East,
and Africa.
The Aixplorer MACH 30 pushes the limits
of breast ultrasound imaging with its innovative modes such as
ShearWave elastography PLUS which improves the characterisation of
lesions and helps reducing the number of biopsies
performed.
The Aixplorer MACH 30 ultrasound platform,
equipped with the latest generation of SWE™ PLUS, offers a
cutting-edge solution for breast imaging with increased speed and
acquisition depth. SWE PLUS, available in both 2D and 3D3,
strengthens diagnostic performances of conventional ultrasonography
by improving the characterisation and specificity exams of breast
lesions. It also helps clinicians visualise and assess
tissue stiffness in real time using a reliable,
quantitative, and reproducible method. This criterion has
become an important parameter for the diagnostic of breast lesions
and the assessment the breast cancer grade.
This new information helps improve the ability
to identify whether a lesion is malignant or benign. It offers
greater diagnostic precision, thus considerably reducing the number
of false positives and unnecessary biopsies.
Other innovative imaging modes developed by
SuperSonic Imagine help improve the diagnostic efficacy of breast
exams and increase the comfort level of radiologists and patients
alike. The quality of B-mode with SonicPure is optimised and offers
better penetration and contrast resolution. This is particularly
helpful for adapting to different morphologies, especially dense
breasts. For imaging the micro-vascularisation of lesions,
the Angio PL.U.S. mode offers unparalleled
sensitivity and resolution, TriVu (Mode-B + SWE +
Color+) is the unique new three-part mode combining three pieces of
diagnostic information in a single exam. Finally,
the Needle PL.U.S4 mode provides doctors with
increased reliability of interventions with ultrasound-guided
biopsies. Applying it helps to simultaneously visualise anatomical
structures, reinforce biopsy needles signal and to predict their
trajectory in real time with a high level of accuracy.
In order to better take the doctor's comfort
into account, SuperSonic Imagine is creating an innovative
SonicPad™ touchpad for ultrasonography with a new
ergonomic design to help improve user experience.
Learn more about Aixplorer® MACH 30 at Aixplorer-MACH.com
About SuperSonic Imagine
SuperSonic Imagine is a medical technology
company (medtech) specialised in ultrasound imaging. The company
designs, produces, and markets an ultrasound system using
UltraFast™, an exclusive technology that has given rise to new
imaging modes. These modes now set the standards in non-invasive
care for characterising diseases of the breast, liver and prostate.
The first innovative UltraFast™ mode is ShearWaveTM elastography
(SWE™) which helps doctors visualise and analyse the hardness of
tissues instantaneously. This information is critical for
diagnosing many conditions. Over 600 publications have confirmed
the benefits of this technology to date. The Aixplorer® MACH 30
ultrasound platform, the most recent addition to the Aixplorer
product range, introduces the next generation of UltraFast™
imaging, optimising all these innovative imaging modes: ShearWave
PLUS, Doppler UltraFast, Angio PL.U.S, and TriVu. With more than
2,300 ultrasound systems installed worldwide, SuperSonic Imagine
has a presence in more than 80 countries and its main markets are
China, the United States, and France. In 2018, the company
generated a turnover of €24.6 million. SuperSonic Imagine is listed
on Euronext (ticker symbol: SSI).
For more information, visit
www.supersonicimagine.com.
Contacts
FP2COM Media Relations -
EUFlorence Portejoiefportejoie@fp2com.fr +33 (0)6 07 76 82 83 |
NewCap Investor
Relations – EU Thomas Grojean / Nicolas Merigeau
supersonicimagine@newcap.eu+33 (0)1 44 71 98 55 |
1 Berg WA et al. Detection of breast cancer with addition of
annual screening ultrasound or a single screening MRI to
mammography in women with elevated breast cancer risk. JAMA. 2012
Apr 4; 307(13): 1394-404.
2 Lee SH et al. Evaluation of Screening
US-detected Breast Masses by Combined Use of Elastography and Color
Doppler US with B-Mode US in Women with Dense Breasts: A
Multicenter Prospective Study. Radiology. 2017 Nov; 285(2):
660-669.
3 3D SWE PLUS mode is available on Aixplorer and will soon be
available on Aixplorer MACH 30
4 The Needle PL.U.S mode is available on Aixplorer and will soon
be available on Aixplorer MACH 30